BRIEF-Pascal Biosciences acquires technology to treat leukemia from the University of New Mexico By: Reuters: Company News September 11, 2017 at 09:12 AM EDT * Pascal Biosciences Inc - has executed an exclusive, worldwide license option agreement with STC Read More >> Related Stocks: Biommune Technologie